Related Experiment Video
Updated: May 1, 2026

Murine Model of Thoracic Aortic Dissection Induced by Oral β-Aminopropionitrile and Subcutaneous Angiotensin II Infusion
Published on: May 16, 2025
Possible extracardiac predictors of aortic dissection in Marfan syndrome
Bence Agg, Kálmán Benke1, Bálint Szilveszter
1Heart and Vascular Center, Semmelweis University, Városmajor str, 68, 1122 Budapest, Hungary. kalman.benke@gmail.com.
Background:
According to previous studies, aortic diameter alone seems to be insufficient to predict the event of aortic dissection in Marfan syndrome (MFS). Determining the optimal schedule for preventive aortic root replacement (ARR) aortic growth rate is of importance, as well as family history, however, none of them appear to be decisive. Thus, the aim of this study was to search for potential predictors of aortic dissection in MFS.
Methods:
A Marfan Biobank consisting of 79 MFS patients was established. Thirty-nine MFS patients who underwent ARR were assigned into three groups based on the indication for surgery (dissection, annuloaortic ectasia and prophylactic surgery). The prophylactic surgery group was excluded from the study. Transforming growth factor-β (TGF-β) serum levels were measured by ELISA, relative expression of c-Fos, matrix metalloproteinase 3 and 9 (MMP-3 and -9) were assessed by RT-PCR. Clinical parameters, including anthropometric variables - based on the original Ghent criteria were also analyzed.
Results:
Among patients with aortic dissection, TGF-β serum level was elevated (43.78 ± 6.51 vs. 31.64 ± 4.99 ng/l, p < 0.0001), MMP-3 was up-regulated (Ln2α = 1.87, p = 0.062) and striae atrophicae were more common (92% vs. 41% p = 0.027) compared to the annuloaortic ectasia group.
Conclusions:
We found three easily measurable parameters (striae atrophicae, TGF-β serum level, MMP-3) that may help to predict the risk of aortic dissection in MFS. Based on these findings a new classification of MFS, that is benign or malignant is also proposed, which could be taken into consideration in determining the timing of prophylactic ARR.
Insights
Predicting aortic dissection in Marfan syndrome (MFS) is crucial. Easily measurable factors like TGF-β serum levels, MMP-3, and striae atrophicae may help identify high-risk MFS patients for timely aortic root replacement.
Area of Science:
- Cardiovascular Research
- Genetics and Genomics
- Biomarker Discovery
Background:
- Aortic diameter alone is insufficient for predicting aortic dissection in Marfan syndrome (MFS).
- Optimal timing for preventive aortic root replacement (ARR) in MFS is challenging.
- Family history and aortic growth rate are not decisive predictors for MFS complications.
Purpose of the Study:
- To identify novel predictors of aortic dissection in Marfan syndrome.
- To investigate the role of TGF-β serum levels and MMP expression in MFS aortic dissection.
- To explore clinical parameters for risk stratification in MFS patients.
Main Methods:
- Established a Marfan Biobank with 79 MFS patients.
- Analyzed 39 MFS patients who underwent ARR, categorized by surgical indication.
- Measured TGF-β serum levels (ELISA) and MMP-3/MMP-9 expression (RT-PCR); assessed clinical parameters.
Main Results:
- Elevated TGF-β serum levels (p < 0.0001) and increased MMP-3 expression (p = 0.062) in patients with aortic dissection compared to the annuloaortic ectasia group.
- Striae atrophicae were significantly more common in the dissection group (92% vs. 41%, p = 0.027).
- TGF-β serum level, MMP-3, and striae atrophicae emerged as potential predictors.
Conclusions:
- Striae atrophicae, TGF-β serum level, and MMP-3 are easily measurable parameters that may predict aortic dissection risk in MFS.
- Proposed a new classification of MFS as benign or malignant based on these predictors.
- Findings could aid in determining the optimal timing for prophylactic ARR in MFS patients.
Related Concept Videos
Aneurysm I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Aortic Regurgitation III: Medical Management
Aortic Regurgitation I: Introduction

